Middle East and Africa Bioreactors Market Growth was valued at USD 14.3 million in 2019 and is expected to witness over 4.5% CAGR from 2020 to 2026.
Bioreactors are development or manufacturing equipment that support biologically active environment for various microorganisms in bioprocessing. These are culture systems broadly used in the areas of biopharmaceuticals, chemicals and food manufacturing among others.
Get more details on this report - Request Free Sample PDF
Growing biopharmaceuticals industry will primarily drive the bioreactors market growth in the Middle East and Africa region. Increasing need for effective therapeutic drugs and vaccines contribute to increase in number of R&D activities that will subsequently create demand for advanced bioreactors to prevent cross contamination and receive better yield. Expansion of manufacturing capacities to cater to growing demand for biopharmaceuticals also influences supply of bioreactors in these facilities. Thus, with increasing penetration of global biopharma manufacturers in Middle Eastern countries will spur the bioreactors industry growth in the forthcoming years.
Middle East and Africa Market, By Product Type
Bioreactors market is segmented as single-use bioreactors and reusable bioreactors based on product type. Single-use bioreactors segment was valued over USD 6.5 million in 2019 and forecasted to foresee lucrative growth rate in the coming years. Advantages associated with single-use bioreactors include reduced capital investment and minimized risk of cross-contamination, that render them favourable for several end-users. Furthermore, increased productivity and cost-associated benefits will aid in boosting segmental size in the region.
Middle East and Africa Market, By Cell
Bioreactors market is segmented on the basis of cell as mammalian cells, bacterial cells, yeast cells and others. Mammalian cells segment is forecasted to grow at 5.1% CAGR during the analysis period. Mammalian cells have applications in bioprocessing of viral vaccines, therapeutic and diagnostic proteins. The stirred-tank bioreactors are commonly used for these cell cultures due to high cell adherence. Therefore, increasing use of mammalian cells in biopharmaceuticals manufacturing will ultimately boost the demand for bioreactor systems in upcoming years.
Middle East and Africa Market, By Molecule
Based on molecule, bioreactors market is segmented as monoclonal antibodies, vaccines, recombinant proteins, stem cells, gene therapy and others. Vaccines segment held over 49% market share in 2019 and is projected to show similar trend during forecast timeline. Effectiveness of vaccines against preventable infectious diseases will escalate the product demand. Additionally, occurrence of pandemic situations increases focus on research in vaccines space. For instance, emergence of COVID-19 has led to huge demand for vaccines and hence, firms are increasing their R&D and production capacities. Thus, continuous emphasis on vaccine development will supplement the segmental growth in future.
Middle East and Africa Market, By End-user
On the basis of end-users, bioreactors market is segmented as R&D organizations, biopharmaceutical manufacturers, contract manufacturing organizations (CMOs). R&D organizations held over 28% revenue share in 2019 and is estimated to witness robust growth over period. Increasing funding by government for research and organizational efforts pertaining to growing incidence of diseases will augment the segment growth potential. Rising investment enhances purchasing capabilities of small R&D organizations, thereby stimulating the adoption of advanced equipment. Therefore, aforementioned factors will continue offer robust opportunities for segmental expansion.
Middle East and Africa Market, By Country
South Africa bioreactors market is projected to exceed USD 5.0 million by 2026 owing to rising prevalence of infectious diseases in the country. South Africa is the country with major HIV affected population, constituting around 20.4% of general population. The government is undertaking certain initiatives to reduce disease burden and expanding biotechnology industry in the country. This will spur vaccines and drug development and impel the demand for bioreactors in the country, thereby offering immense opportunities for market players.
Competitive Market Share
Some of the major industry players involved in Middle East and Africa bioreactors market include Applikon Biotechnology, Merck Group, Thermo Fisher Scientific, Sartorius Group and Eppendorf AG among others. Key players are undertaking various strategies such as collaborations, mergers & acquisitions and product development to sustain market competition as well as strengthen their market position. For instance, in March 2019, Applikon Biotechnology in collaboration with Emerson launched V-control technology for R&D scale bioreactors. Such product development and advancements offer competitive edge to the company.
Bioreactors was known in biotechnology since 1940s, however, its commercial use started in between 1960s and 1970s. Stirred-tank bioreactors have long history and are still used in large industries. The introduction of single-use technology has changed the scenario in research and manufacturing. R&D and pilot scale manufacturers provided preference for these systems due to its flexibility and cost-effectiveness. With further advancements, the companies are focusing on extension of volume capacities of single-use systems. Expansion of biotechnology and pharmaceutical business in the Middle East and Africa will propel the demand for such systems in coming future.